Maybe you are talking about most of the Canadian Industry? This company has plenty of shares to sell still, as do most. They turned the ship around a while back, claimed ebita positive last earnings. They need to get their internal costs down. They sold off alot of assets, but they have a unique situation going on with their sky facility with bevo. Still a high risk here, just like tilray and cgc, imo acb is a better company than cgc, but cgc has a very strong partnership. Tilray is still on a spending spree. My opinion is Acb will go up when medical gets legalized in the USA. Acb is already in Germany, where Germany will be legal this year as well(its a small rollout, but it's a start). Many investors have averaged down, I'm not till I see a better spark. If I was new here, I'd probably toss in a little at this price, or wait till they figure out what they plan on doing about being under 1$ on the NASDAQ
Bullish
News 
Market Data 
Discover 
AI
